Pseudomonas putida bacteremia in pediatric patients: A case series study

Micaela Picollo1, Daiana Karina Ferraro1, Guadalupe Pérez1

  • 1Epidemiological Control and Infectious Disease Service, Hospital Nacional de Pediatría SAMIC Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina.

Abstract

Insights

Emerging antibiotic resistance in Pseudomonas putida bacteremia is a concern in hospitalized children. This study highlights clinical features and resistance patterns in pediatric patients, emphasizing the need for local epidemiological data.

Area of Science:

  • Clinical Microbiology
  • Infectious Diseases
  • Pediatric Infectious Diseases

Background:

  • Pseudomonas putida, typically an opportunistic pathogen of low virulence, is increasingly associated with antibiotic-resistant infections.
  • The emergence of multidrug-resistant strains necessitates a better understanding of P. putida bacteremia in vulnerable populations.
  • Pediatric patients with underlying comorbidities are particularly susceptible to severe outcomes from bacterial infections.

Purpose of the Study:

  • To characterize the clinical presentation, treatment course, and antibiotic resistance patterns of Pseudomonas putida bacteremia in hospitalized pediatric patients.
  • To identify risk factors and common sources of P. putida bacteremia in a pediatric cohort.
  • To inform clinical management and public health strategies regarding P. putida infections.

Main Methods:

  • Retrospective case series including pediatric patients with P. putida isolated from blood cultures.
  • Data collected from Prof. Dr. Juan P. Garrahan Hospital, Buenos Aires City, Argentina, between August 2015 and August 2020.
  • Analysis of clinical characteristics, comorbidities, infection sources, treatment, and antibiotic susceptibility.

Main Results:

  • A total of 13 pediatric patients were included, with a median age of 81 months.
  • The majority of patients were immunocompromised (77%) and had central venous catheters (85%), with catheter-associated bacteremia being the predominant source (77%).
  • Significant carbapenem resistance (30%) was observed, alongside variable antibiotic sensitivities. Two patients developed septic shock, and none died.

Conclusions:

  • Pseudomonas putida bacteremia in hospitalized children often occurs in immunocompromised individuals with central venous catheters.
  • The prevalence of multidrug-resistant strains, including carbapenem resistance, underscores the importance of local antimicrobial stewardship.
  • Understanding the evolving epidemiology of P. putida is crucial for effective clinical management and infection control in pediatric settings.